Targeted sequencing reveals molecular differences in low-grade and transformed components of ovarian tumors, suggesting prognostic insights.
Targeted sequencing analysis of matched low-grade and higher-grade components from ovarian low-grade serous tumors with histologic transformation
No takes yet. Share an insight, caveat, or question.
Chui et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: